VistaGen Therapeutics
VTGN
#10067
Rank
โ‚ฌ22.24 M
Marketcap
0,56ย โ‚ฌ
Share price
-2.39%
Change (1 day)
-82.44%
Change (1 year)

Market capitalization of VistaGen Therapeutics (VTGN)

Market cap: โ‚ฌ22.24 Million

As of January 2026 VistaGen Therapeutics has a market cap of โ‚ฌ22.24 Million. This makes VistaGen Therapeutics the world's 10067th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of VistaGen Therapeutics from 2011 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ24.48 M-64.39%
2024โ‚ฌ68.76 M-45.27%
2023โ‚ฌ0.12 B532.64%
2022โ‚ฌ19.86 M-94.22%
2021โ‚ฌ0.34 B58.95%
2020โ‚ฌ0.21 B712.93%
2019โ‚ฌ26.61 M-34.65%
2018โ‚ฌ40.72 M100.85%
2017โ‚ฌ20.27 M-31.77%
2016โ‚ฌ29.71 M80.49%
2015โ‚ฌ16.46 M77.77%
2014โ‚ฌ9.26 M34.86%
2013โ‚ฌ6.86 M-35.69%
2012โ‚ฌ10.67 M-71.71%
2011โ‚ฌ37.75 M
2026โ‚ฌ22.24 M-9.16%

End of Day market cap according to different sources

On Jan 1st, 2026 the market cap of VistaGen Therapeutics was reported to be:

โ‚ฌ22.24 Million
by Nasdaq info icon info icon
โ‚ฌ22.24 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
ORIC Pharmaceuticals
ORIC
โ‚ฌ0.67 B 2,947.37%๐Ÿ‡บ๐Ÿ‡ธ USA